Topics

Biopharma analyst: Excitement/Skepticism building over new Alzheimer’s drug

12:04 EST 10 Nov 2019 | MedCity News

Vector illustration of Approved green ink stamp

Chinese regulators gave conditional approval to a new drug with a different mechanism of action giving new hope to Alzheimer’s Disease patients and while the excitement is warranted so is skepticism.

Original Article: Biopharma analyst: Excitement/Skepticism building over new Alzheimer’s drug

NEXT ARTICLE

More From BioPortfolio on "Biopharma analyst: Excitement/Skepticism building over new Alzheimer’s drug"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...